Research Topics
| David FiellinSummaryAffiliation: Yale University Country: USA Publications
Research Grants
| Collaborators
|
Detail Information
Publications
A randomized trial of cognitive behavioral therapy in primary care-based buprenorphineDavid A Fiellin
Department of Internal Medicine, Yale University School of Medicine, New Haven, CT 06520 8093, USA
Am J Med 126:74.e11-7. 2013..To determine the impact of cognitive behavioral therapy on outcomes in primary care, office-based buprenorphine/naloxone treatment of opioid dependence...
Beyond diagnosis: patient mix and challenges to patient care in ambulatory training sitesD A Fiellin
Department of Internal Medicine, Yale University School of Medicine, New Haven, CT 06520 8025, USA
Am J Med Sci 319:106-10. 2000..Educational experiences in ambulatory medicine vary by site. Purpose: To evaluate variations in patient mix and challenges in patient care at 3 ambulatory training sites...
Long-term treatment with buprenorphine/naloxone in primary care: results at 2-5 yearsDavid A Fiellin
Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut 06520 8025, USA
Am J Addict 17:116-20. 2008..Serum transaminases remained stable from baseline. No serious adverse events related to treatment occurred. We conclude that select opioid-dependent patients exhibit moderate levels of retention in primary care office-based treatment...
Counseling plus buprenorphine-naloxone maintenance therapy for opioid dependenceDavid A Fiellin
Department of Internal Medicine, Yale University School of Medicine, New Haven, Conn 06520, USA
N Engl J Med 355:365-74. 2006..The optimal level of counseling and frequency of attendance for medication distribution has not been established for the primary care, office-based buprenorphine-naloxone treatment of opioid dependence...
Consensus statement on office-based treatment of opioid dependence using buprenorphineDavid A Fiellin
Department of Internal Medicine, Yale University School of Medicine, New Haven, CT, USA
J Subst Abuse Treat 27:153-9. 2004....
Processes of care during a randomized trial of office-based treatment of opioid dependence in primary careDavid A Fiellin
Department of Internal Medicine, Yale University School of Medicine, 333 Cedar Street, PO Box 208025, New Haven, CT 06520 8025, USA
Am J Addict 13:S67-78. 2004..Chart audits and mentoring should be considered as a mechanism to foster quality care. These processes of care are likely to require attention for treatment using methadone or buprenorphine...
Opioid dependence: rationale for and efficacy of existing and new treatmentsDavid A Fiellin
Yale University School of Medicine, New Haven, CT 06520 8025, USA
Clin Infect Dis 43:S173-7. 2006..This review focuses on the neurobiological basis of opioid dependence, the rationale for methadone and buprenorphine treatments, and issues in prescribing these medications to patients with HIV infection...
Drug treatment outcomes among HIV-infected opioid-dependent patients receiving buprenorphine/naloxoneDavid A Fiellin
Departments of Internal Medicine, Yale University School of Medicine, New Haven, CT 06520 8093, USA
J Acquir Immune Defic Syndr 56:S33-8. 2011..Buprenorphine/naloxone allows the integration of opioid dependence and HIV treatment...
Guideline development for office-based pharmacotherapies for opioid dependenceDavid A Fiellin
Department of Internal Medicine, Yale University School of Medicine, New Haven, CT 06520 8025, USA
J Addict Dis 22:109-20. 2003..We outline the process and describe the two guidelines that were produced by this process that are targeted at physicians, narcotic treatment programs, and policy makers...
Screening for alcohol problems in primary care: a systematic reviewD A Fiellin
Yale University School of Medicine, 333 Cedar St, PO Box 208025, New Haven, CT 06520 8025, USA
Arch Intern Med 160:1977-89. 2000..Primary care physicians can play a unique role in recognizing and treating patients with alcohol problems...
Coordination of medical care and opioid dependence treatment in primary care: a case reportDavid A Fiellin
Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut
Subst Abus 24:43-6. 2003
Risk for delirium tremens in patients with alcohol withdrawal syndromeDavid A Fiellin
Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut 06520 8025, USA
Subst Abus 23:83-94. 2002..8 (95% CI 4.36-460). Elevated blood pressure, prior complicated alcohol withdrawal and medical comorbidity, alone and in combination, are associated with an increased risk of delirium tremens...
New federal initiatives to enhance the medical treatment of opioid dependenceDavid A Fiellin
Yale University School of Medicine, 333 Cedar Street, PO Box 208025, New Haven, CT 06520 8025, USA
Ann Intern Med 137:688-92. 2002..This perspective describes these initiatives and their implications for internists...
Clinical practice. Office-based treatment of opioid-dependent patientsDavid A Fiellin
Department of Internal Medicine, Yale University School of Medicine, New Haven, Conn 06520-8025, USA
N Engl J Med 347:817-23. 2002
Methadone maintenance in primary care: a randomized controlled trialD A Fiellin
Yale University School of Medicine, 333 Cedar St, PO Box 208025, New Haven, CT 06520 8025, USA
JAMA 286:1724-31. 2001..Office-based care of stabilized methadone maintenance patients is a promising alternative but no data are available from controlled trials regarding this type of program...
Treatment of heroin dependence with buprenorphine in primary careDavid A Fiellin
Department of Internal Medicine, Yale University School of Medicine, New Haven, CT 06520 8025, USA
Am J Drug Alcohol Abuse 28:231-41. 2002..Eleven patients (79%) were retained through the maintenance phase. We conclude that buprenorphine maintenance is feasible in a primary care setting...
Substance use of disorders in HIV-infected patients: impact and new treatment strategiesDavid A Fiellin
Yale University School of Medicine, New Haven, CT, USA
Top HIV Med 12:77-82. 2004..This article summarizes a presentation by David A. Fiellin, MD, in March 2004 at the International AIDS Society-USA New York course...
Faculty development in small-group teaching skills associated with a training course on office-based treatment of opioid dependenceJeffrey G Wong
Yale University School of Medicine, USA
Subst Abus 25:35-40. 2004..Evaluation of the DATA-2000 training session small-group facilitators was uniformly positive. This faculty development workshop was successful in improving teaching skills for our small-group faculty facilitators...
Provider satisfaction with office-based treatment of opioid dependence: a systematic reviewWilliam C Becker
Department of Internal Medicine, Yale University School of Medicine, New Haven, CT 06520-8025, USA
Subst Abus 26:15-22. 2005..Further research, designed to identify the barriers to provider satisfaction with office-based opioid agonist therapy, is needed to ensure that these barriers do not limit expansion of this practice...
Cost analysis of clinic and office-based treatment of opioid dependence: results with methadone and buprenorphine in clinically stable patientsEmlyn S Jones
Department of Internal Medicine, Section of General Internal Medicine, Yale University School of Medicine, 333 Cedar St, P O Box 208025, New Haven, CT, United States
Drug Alcohol Depend 99:132-40. 2009..We conclude that providing clinic-based methadone is least expensive. The price of buprenorphine accounts for a major portion of the difference in costs. For patients, office-based treatment may be less expensive...
Gender and non-medical use of prescription opioids: results from a national US surveyJeanette M Tetrault
Veterans Affairs Clinical Epidemiology Research Center, West Haven, CT, USA
Addiction 103:258-68. 2008..Gender differences exist regarding alcohol and illicit drug use disorders in the United States. Little is known about the gender-related factors associated with non-medical use of prescription opioids...
Buprenorphine/naloxone treatment in primary care is associated with decreased human immunodeficiency virus risk behaviorsLynn E Sullivan
Department of Internal Medicine, Yale University School of Medicine, New Haven, CT, USA
J Subst Abuse Treat 35:87-92. 2008..We conclude that primary-care-based buprenorphine/naloxone treatment is associated with decreased drug-related HIV risk, but additional efforts may be needed to address sex-related HIV risk when present...
Non-medical use, abuse and dependence on sedatives and tranquilizers among U.S. adults: psychiatric and socio-demographic correlatesWilliam C Becker
Department of Internal Medicine, Yale University School of Medicine, New Haven, CT 06520 8025, United States
Drug Alcohol Depend 90:280-7. 2007..Non-medical use of sedatives and tranquilizers carries risks including development of abuse/dependence. Such use may correlate with psychiatric symptoms...
Effects of marijuana smoking on pulmonary function and respiratory complications: a systematic reviewJeanette M Tetrault
Clinical Epidemiology Research Center, Department of Veterans Affairs Connecticut Healthcare System, West Haven Veterans Affairs Medical Center, 950 Campbell Avenue, West Haven, CT 06516, USA
Arch Intern Med 167:221-8. 2007....
Primary care office-based buprenorphine treatment: comparison of heroin and prescription opioid dependent patientsBrent A Moore
Department of Psychiatry, Yale University School of Medicine, New Haven, Connecticut 06519, USA
J Gen Intern Med 22:527-30. 2007..Prescription opioid dependence is increasing, but treatment outcomes with office-based buprenorphine/naloxone among these patients have not been described...
Patient satisfaction with primary care office-based buprenorphine/naloxone treatmentDeclan T Barry
Department of Psychiatry, Yale University School of Medicine, New Haven, CT 06519 1187, USA
J Gen Intern Med 22:242-5. 2007..Factors associated with satisfaction among patients receiving primary care-based buprenorphine/naloxone are unknown...
Non-medical use, abuse and dependence on prescription opioids among U.S. adults: psychiatric, medical and substance use correlatesWilliam C Becker
Department of Internal Medicine, Yale University School of Medicine, New Haven, CT 06520 8025, United States
Drug Alcohol Depend 94:38-47. 2008..Non-medical use of prescription opioids carries risks including development of abuse/dependence. Such use may correlate with psychiatric, medical, and substance use characteristics...
Brief intervention for hazardous and harmful drinkers in the emergency departmentGAIL D'ONOFRIO
Section of Emergency Medicine, Yale University School of Medicine, New Haven, CT 06519, USA
Ann Emerg Med 51:742-750.e2. 2008..To determine the efficacy of emergency practitioner-performed brief intervention for hazardous/harmful drinkers in reducing alcohol consumption and negative consequences in an emergency department (ED) setting...
Integrating buprenorphine treatment into office-based practice: a qualitative studyDeclan T Barry
Department of Psychiatry, Yale University School of Medicine, New Haven, CT 06519 1187, USA
J Gen Intern Med 24:218-25. 2009..Despite the availability and demonstrated effectiveness of office-based buprenorphine maintenance treatment (BMT), the systematic examination of physicians' attitudes towards this new medical practice has been largely neglected...
The association between cocaine use and treatment outcomes in patients receiving office-based buprenorphine/naloxone for the treatment of opioid dependenceLynn E Sullivan
Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut 06520 8093, USA
Am J Addict 19:53-8. 2010..35%, p = .001). We conclude that both baseline and in-treatment cocaine use is associated with worse treatment outcomes in patients receiving office-based buprenorphine/naloxone and may benefit from targeted interventions...
Substance use in patients with sexually transmitted infections: results from a national U.S. surveyJeanette M Tetrault
Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut, USA
Am J Addict 19:504-9. 2010..A diagnosis of an STI should prompt clinicians to screen for substance use, in particular, alcohol abuse/dependence and marijuana use. ..
HIV treatment outcomes among HIV-infected, opioid-dependent patients receiving buprenorphine/naloxone treatment within HIV clinical care settings: results from a multisite studyFrederick L Altice
Yale University School of Medicine, New Haven, CT, USA
J Acquir Immune Defic Syndr 56:S22-32. 2011..Having opioid dependence and HIV infection are associated with poor HIV-related treatment outcomes...
The impact of cocaine use on outcomes in HIV-infected patients receiving buprenorphine/naloxoneLynn E Sullivan
Department of Internal Medicine, Yale University School of Medicine, New Haven, CT 06520 8093, USA
J Acquir Immune Defic Syndr 56:S54-61. 2011..Cocaine use is common in opioid-dependent HIV-infected patients, but its impact on treatment outcomes in these patients receiving buprenorphine/naloxone is not known...
The case for routine HIV screening and impact of managed careLynn E Sullivan
Department of Internal Medicine, Yale University School of Medicine, New Haven, CT 06520 8093, USA
Am J Manag Care 16:S345-51. 2010..Given the public health impact of HIV infection, federal and private partnerships should be considered to establish routine HIV screening practices...
Narrative review: buprenorphine for opioid-dependent patients in office practiceLynn E Sullivan
Yale University School of Medicine, New Haven, Connecticut 06520 8093, USA
Ann Intern Med 148:662-70. 2008..The different components of treatment; the role of the physician who provides this treatment; and the logistics of treating this growing, multifaceted patient population are also examined...
Systematic review: opioid treatment for chronic back pain: prevalence, efficacy, and association with addictionBridget A Martell
Yale University School of Medicine, New Haven, Connecticut 06520 8025, USA
Ann Intern Med 146:116-27. 2007..The prevalence, efficacy, and risk for addiction for persons receiving opioids for chronic back pain are unclear...
Gambling: an addictive behavior with health and primary care implicationsMarc N Potenza
Yale University School of Medicine, New Haven, CT 06519, USA
J Gen Intern Med 17:721-32. 2002....
The practice of office-based buprenorphine treatment of opioid dependence: is it associated with new patients entering into treatment?Lynn E Sullivan
Department of Internal Medicine, Yale University School of Medicine, 333 Cedar Street, P O Box 208025, New Haven, CT 06520 8025, USA
Drug Alcohol Depend 79:113-6. 2005..Treatment outcomes with buprenorphine in a PCC do not vary based on history of prior methadone treatment...
Primary intensive care: pilot study of a primary care-based intervention for high-utilizing patientsKaren E Brown
Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut 06508, USA
Dis Manag 8:169-77. 2005..Patient and staff satisfaction was high, although the intervention was very difficult for the providers...
Buprenorphine: its role in preventing HIV transmission and improving the care of HIV-infected patients with opioid dependenceLynn E Sullivan
Yale University School of Medicine, New Haven, Connecticut 06520 8025, USA
Clin Infect Dis 41:891-6. 2005..This review addresses the introduction of buprenorphine, in terms of public health, policy, and clinical implications for HIV-infected patients and for HIV care providers...
Development and implementation of an emergency practitioner-performed brief intervention for hazardous and harmful drinkers in the emergency departmentGAIL D'ONOFRIO
Section of Emergency Medicine, Yale University School of Medicine, 464 Congress Avenue, Suite 260, New Haven, CT 06519, USA
Acad Emerg Med 12:249-56. 2005....
A randomized trial of primary intensive care to reduce hospital admissions in patients with high utilization of inpatient servicesWilliam H Sledge
Department of Psychiatry, Yale University School of Medicine, Yale New Haven Psychiatric Hospital, New Haven, Connecticut 06519, USA
Dis Manag 9:328-38. 2006..We were unable to detect a difference in hospital use or functional status, mental health function, or medication adherence among patients who require frequent hospital admissions using our intervention...
Decreasing international HIV transmission: the role of expanding access to opioid agonist therapies for injection drug usersLynn E Sullivan
Yale University School of Medicine, New Haven, CT 06520 8025, USA
Addiction 100:150-8. 2005..To examine the role of expanded access to opioid agonist treatment as a means to decrease international HIV transmission...
Buprenorphine for office-based practice: consensus conference overviewThomas R Kosten
Department of Psychiatry, Yale University School of Medicine, New Haven, CT 06516, USA
Am J Addict 13:S1-7. 2004..This opportunity has a three-year window, however, and a critical need will be to attract a sufficient number of physicians into prescribing buprenorphine/naloxone in order to allow our patients increased access to this treatment...
Hepatitis C and HIV infections: implications for clinical care in injection drug usersLynn E Sullivan
Department of Internal Medicine, Yale University School of Medicine, 333 Cedar Street, PO Box 208025, New Haven, CT 06520 8025, USA
Am J Addict 13:1-20. 2004..Providers caring for patients who are or were IDUs must be aware of the management of these diseases and make efforts to integrate their medical care with the treatment of their substance abuse...
Training HIV physicians to prescribe buprenorphine for opioid dependenceLynn E Sullivan
Department of Internal Medicine, Yale University School of Medicine, New Haven, CT 6520 8025, USA
Subst Abus 27:13-8. 2006..HIV physicians' concerns regarding interactions between buprenorphine and HAART need to be addressed in future training efforts...
Effect of incarceration history on outcomes of primary care office-based buprenorphine/naloxoneEmily A Wang
Department of Internal Medicine, Yale University School of Medicine, New Haven, CT 06510, USA
J Gen Intern Med 25:670-4. 2010..Behaviors associated with opioid dependence often involve criminal activity, which can lead to incarceration. The impact of a history of incarceration on outcomes in primary care office-based buprenorphine/naloxone is not known...
Initial strategies for integrating buprenorphine into HIV care settings in the United StatesLynn E Sullivan
Yale University School of Medicine, New Haven, CT 06520 8025, USA
Clin Infect Dis 43:S191-6. 2006....
A trial of integrated buprenorphine/naloxone and HIV clinical careLynn E Sullivan
Department of Internal Medicine, Yale University School of Medicine, New Haven, CT 06520 8025, USA
Clin Infect Dis 43:S184-90. 2006..We investigated the feasibility and efficacy of integrating buprenorphine, along with 2 levels of counseling, into HIV clinical care...
The prevalence and impact of alcohol problems in major depression: a systematic reviewLynn E Sullivan
Department of Internal Medicine, Yale University School of Medicine, 333 Cedar Street, New Haven, CT 06520, USA
Am J Med 118:330-41. 2005..In addition, the literature focuses almost exclusively on patients with alcohol abuse or dependence in psychiatric inpatient settings, and excludes patients with less severe alcohol problems and primary care outpatient settings...
Opioids, chronic pain, and addiction in primary careDeclan T Barry
Department of Psychiatry, Yale University School of Medicine, New Haven, Connecticut, USA
J Pain 11:1442-50. 2010..Addressing these barriers in physician training and in existing office-based programs might benefit both noncancer chronic pain patients and their medical providers...
Women and opioid dependence treatment: office-based versus opioid treatment program-based care?Emlyn S Jones
Department of Internal Medicine, Yale University School of Medicine, New Haven, CT 06520 8025, USA
Subst Abus 28:3-8. 2007..Nonetheless office-based treatment may provide a solution for women concerned about anonymity, stigma, and the requirement of daily visits to a MMP...
Utility of sweat patch testing for drug use monitoring in outpatient treatment for opiate dependenceMarek C Chawarski
Yale University School of Medicine, New Haven, CT 06519, USA
J Subst Abuse Treat 33:411-5. 2007..3% were brought back attached to the skin) and that weekly sweat testing is less sensitive than weekly urine testing in detecting opiate use, suggest limited utility of sweat patch testing in outpatient clinical settings...
The payoff time: a flexible framework to help clinicians decide when patients with comorbid disease are not likely to benefit from practice guidelinesR Scott Braithwaite
Department of Internal Medicine, Section of General Internal Medicine, Yale University School of Medicine and VA Connecticut Healthcare System, New Haven, Connecticut, USA
Med Care 47:610-7. 2009..Practice guidelines rarely consider comorbid illness, and resulting overuse of health services may increase costs without conferring benefit...
Patterns of drug use and abuse among aging adults with and without HIV: a latent class analysis of a US Veteran cohortTraci C Green
Division of Chronic Disease Epidemiology, Yale School of Public Health, New Haven, CT, United States
Drug Alcohol Depend 110:208-20. 2010..Findings have the potential to inform screening and intervention efforts in aging drug users with and without HIV...
Connecticut statewide addiction medicine/psychiatry grand roundsMark L Kraus
Yale University School of Medicine, New Haven, Conneticut, USA
Conn Med 67:357-9. 2003
Depression symptoms and treatment among HIV infected and uninfected veteransKristen Sueoka
Yale University School of Medicine, New Haven, CT, USA
AIDS Behav 14:272-9. 2010..09, 95% CI 1.04, 4.24). Primary care and HIV providers were equally unlikely to treat active depressive symptoms. Treatment variation by race, site, and availability of a mental health provider, suggests targets for intervention...
Quality of care for acute myocardial infarction in elderly patients with alcohol-related diagnosesDavid A Fiellin
Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut 06520-8088, USA
Alcohol Clin Exp Res 30:70-5. 2006..CONCLUSIONS: Alcohol-related diagnoses are not a barrier to receiving most quality of care measures in elderly patients hospitalized for acute myocardial infarction...
Treatment of adolescent opioid dependence: no quick fixDavid A Fiellin
JAMA 300:2057-9. 2008
Methadone syrup injection in Australia: a sentinel finding?David A Fiellin
Addiction 98:385-6. 2003
Update in addiction medicine for the generalistAdam J Gordon
Mental Illness Research, Education, and Clinical Center, University of Pittsburgh, Pittsburgh, PA, USA
J Gen Intern Med 22:1190-4. 2007
Buprenorphine: effective treatment of opioid addiction starts in the officeDavid A Fiellin
Am Fam Physician 73:1513-4. 2006
Mental health after deployment to Iraq or AfghanistanDavid A Fiellin
JAMA 296:515; author reply 516. 2006
Evaluation of a combined online and in person training in the use of buprenorphineErik W Gunderson
Columbia University College of Physicians and Surgeon and New York State Psychiatric Institute, New York, NY, USA
Subst Abus 27:39-45. 2006..Overall, physicians preferred in person instruction and may benefit from additional experiential training and support after curriculum participation...
Office-based maintenance treatment of opioid dependence: how does it compare with traditional approaches?Erik W Gunderson
Columbia University College of Physicians and Surgeons, New York, New York, USA
CNS Drugs 22:99-111. 2008..OBOT is not a replacement for more structured, traditional models of care, but provides an additional opportunity to help address the tremendous public health impact of opioid dependence...
Opioid use disorder in the United States: insurance status and treatment accessWilliam C Becker
Department of Internal Medicine, Philadelphia VAMC, Philadelphia, PA 19104, United States
Drug Alcohol Depend 94:207-13. 2008..In the United States, insurance status and rates of treatment for individuals with opioid use disorder are unknown...
The association between marijuana smoking and lung cancer: a systematic reviewReena Mehra
Department of Medicine, Case Western Reserve University, Cleveland, Ohio 44106 6003, USA
Arch Intern Med 166:1359-67. 2006..Our objective was to assess the impact of marijuana smoking on the development of premalignant lung changes and lung cancer...
Alcohol problems and health care services use in human immunodeficiency virus (HIV)-infected and HIV-uninfected veteransKevin L Kraemer
Center for Research on Health Care, Division of General Internal Medicine, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania 15213, USA
Med Care 44:S44-51. 2006..Although alcohol problems are common in human immunodeficiency virus (HIV)-infected patients, their impact on health care services use in HIV-infected patients is not well understood...
Research Grants
- Counseling for Primary Care Office-Based BuprenorphineDavid Fiellin; Fiscal Year: 2007..The results of this study will help define the role of professional evidence-based drug counseling in expanding access to treatment with Bup. ..
- Buprenorphine Maintenance vs. Detoxification in Prescription Opioid DependenceDavid Fiellin; Fiscal Year: 2007..Relevance to public health: The results of this study will help define the role of maintenance vs. detoxification with buprenorphine in the care of prescription opioid dependent patients in primary care. ..
- Counseling for Primary Care Office-Based BuprenorphineDavid Fiellin; Fiscal Year: 2009..The results of this study will help define the role of professional evidence-based drug counseling in expanding access to treatment with Bup. ..
- Buprenorphine Maintenance vs. Detoxification in Prescription Opioid DependenceDavid Fiellin; Fiscal Year: 2010..Relevance to public health: The results of this study will help define the role of maintenance vs. detoxification with buprenorphine in the care of prescription opioid dependent patients in primary care. ..
